256 related articles for article (PubMed ID: 31012492)
1. Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.
Athreya AP; Neavin D; Carrillo-Roa T; Skime M; Biernacka J; Frye MA; Rush AJ; Wang L; Binder EB; Iyer RK; Weinshilboum RM; Bobo WV
Clin Pharmacol Ther; 2019 Oct; 106(4):855-865. PubMed ID: 31012492
[TBL] [Abstract][Full Text] [Related]
2. Multi-omics driven predictions of response to acute phase combination antidepressant therapy: a machine learning approach with cross-trial replication.
Joyce JB; Grant CW; Liu D; MahmoudianDehkordi S; Kaddurah-Daouk R; Skime M; Biernacka J; Frye MA; Mayes T; Carmody T; Croarkin PE; Wang L; Weinshilboum R; Bobo WV; Trivedi MH; Athreya AP
Transl Psychiatry; 2021 Oct; 11(1):513. PubMed ID: 34620827
[TBL] [Abstract][Full Text] [Related]
3. TSPAN5, ERICH3 and selective serotonin reuptake inhibitors in major depressive disorder: pharmacometabolomics-informed pharmacogenomics.
Gupta M; Neavin D; Liu D; Biernacka J; Hall-Flavin D; Bobo WV; Frye MA; Skime M; Jenkins GD; Batzler A; Kalari K; Matson W; Bhasin SS; Zhu H; Mushiroda T; Nakamura Y; Kubo M; Wang L; Kaddurah-Daouk R; Weinshilboum RM
Mol Psychiatry; 2016 Dec; 21(12):1717-1725. PubMed ID: 26903268
[TBL] [Abstract][Full Text] [Related]
4. The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response.
Biernacka JM; Sangkuhl K; Jenkins G; Whaley RM; Barman P; Batzler A; Altman RB; Arolt V; Brockmöller J; Chen CH; Domschke K; Hall-Flavin DK; Hong CJ; Illi A; Ji Y; Kampman O; Kinoshita T; Leinonen E; Liou YJ; Mushiroda T; Nonen S; Skime MK; Wang L; Baune BT; Kato M; Liu YL; Praphanphoj V; Stingl JC; Tsai SJ; Kubo M; Klein TE; Weinshilboum R
Transl Psychiatry; 2015 Apr; 5(4):e553. PubMed ID: 25897834
[TBL] [Abstract][Full Text] [Related]
5. Glycine and a glycine dehydrogenase (GLDC) SNP as citalopram/escitalopram response biomarkers in depression: pharmacometabolomics-informed pharmacogenomics.
Ji Y; Hebbring S; Zhu H; Jenkins GD; Biernacka J; Snyder K; Drews M; Fiehn O; Zeng Z; Schaid D; Mrazek DA; Kaddurah-Daouk R; Weinshilboum RM
Clin Pharmacol Ther; 2011 Jan; 89(1):97-104. PubMed ID: 21107318
[TBL] [Abstract][Full Text] [Related]
6. Dual Roles for the TSPYL Family in Mediating Serotonin Transport and the Metabolism of Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder.
Qin S; Eugene AR; Liu D; Zhang L; Neavin D; Biernacka JM; Yu J; Weinshilboum RM; Wang L
Clin Pharmacol Ther; 2020 Mar; 107(3):662-670. PubMed ID: 31628858
[TBL] [Abstract][Full Text] [Related]
7. Selective Serotonin Reuptake Inhibitor Pharmaco-Omics: Mechanisms and Prediction.
Nguyen TTL; Liu D; Ho MF; Athreya AP; Weinshilboum R
Front Pharmacol; 2020; 11():614048. PubMed ID: 33510640
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial Pharmacogenomic Algorithm is Predictive of Citalopram and Escitalopram Metabolism in Patients with Major Depressive Disorder.
Shelton RC; Parikh SV; Law RA; Rothschild AJ; Thase ME; Dunlop BW; DeBattista C; Conway CR; Forester BP; Macaluso M; Hain DT; Aguilar AL; Brown K; Lewis DJ; Jablonski MR; Greden JF
Psychiatry Res; 2020 Aug; 290():113017. PubMed ID: 32485484
[TBL] [Abstract][Full Text] [Related]
9. Inclusion of genetic variants in an ensemble of gradient boosting decision trees does not improve the prediction of citalopram treatment response.
Shumake J; Mallard TT; McGeary JE; Beevers CG
Sci Rep; 2021 Feb; 11(1):3780. PubMed ID: 33580158
[TBL] [Abstract][Full Text] [Related]
10. Catechol O-methyltransferase pharmacogenomics and selective serotonin reuptake inhibitor response.
Ji Y; Biernacka J; Snyder K; Drews M; Pelleymounter LL; Colby C; Wang L; Mrazek DA; Weinshilboum RM
Pharmacogenomics J; 2012 Feb; 12(1):78-85. PubMed ID: 20877297
[TBL] [Abstract][Full Text] [Related]
11. New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.
Fabbri C; Tansey KE; Perlis RH; Hauser J; Henigsberg N; Maier W; Mors O; Placentino A; Rietschel M; Souery D; Breen G; Curtis C; Sang-Hyuk L; Newhouse S; Patel H; Guipponi M; Perroud N; Bondolfi G; O'Donovan M; Lewis G; Biernacka JM; Weinshilboum RM; Farmer A; Aitchison KJ; Craig I; McGuffin P; Uher R; Lewis CM
Pharmacogenomics J; 2018 May; 18(3):413-421. PubMed ID: 29160301
[TBL] [Abstract][Full Text] [Related]
12. Treatment outcomes of depression: the pharmacogenomic research network antidepressant medication pharmacogenomic study.
Mrazek DA; Biernacka JM; McAlpine DE; Benitez J; Karpyak VM; Williams MD; Hall-Flavin DK; Netzel PJ; Passov V; Rohland BM; Shinozaki G; Hoberg AA; Snyder KA; Drews MS; Skime MK; Sagen JA; Schaid DJ; Weinshilboum R; Katzelnick DJ
J Clin Psychopharmacol; 2014 Jun; 34(3):313-7. PubMed ID: 24743713
[TBL] [Abstract][Full Text] [Related]
13. Optimizing prediction of response to antidepressant medications using machine learning and integrated genetic, clinical, and demographic data.
Taliaz D; Spinrad A; Barzilay R; Barnett-Itzhaki Z; Averbuch D; Teltsh O; Schurr R; Darki-Morag S; Lerer B
Transl Psychiatry; 2021 Jul; 11(1):381. PubMed ID: 34238923
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic-Pharmacodynamic interaction associated with venlafaxine-XR remission in patients with major depressive disorder with history of citalopram / escitalopram treatment failure.
Ahmed AT; Biernacka JM; Jenkins G; Rush AJ; Shinozaki G; Veldic M; Kung S; Bobo WV; Hall-Flavin DK; Weinshilboum RM; Wang L; Frye MA
J Affect Disord; 2019 Mar; 246():62-68. PubMed ID: 30578947
[TBL] [Abstract][Full Text] [Related]
15. ERICH3: vesicular association and antidepressant treatment response.
Liu D; Zhuang Y; Zhang L; Gao H; Neavin D; Carrillo-Roa T; Wang Y; Yu J; Qin S; Kim DC; Liu E; Nguyen TTL; Biernacka JM; Kaddurah-Daouk R; Dunlop BW; Craighead WE; Mayberg HS; Binder EB; Frye MA; Wang L; Weinshilboum RM
Mol Psychiatry; 2021 Jun; 26(6):2415-2428. PubMed ID: 33230203
[TBL] [Abstract][Full Text] [Related]
16. FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder.
Ellsworth KA; Moon I; Eckloff BW; Fridley BL; Jenkins GD; Batzler A; Biernacka JM; Abo R; Brisbin A; Ji Y; Hebbring S; Wieben ED; Mrazek DA; Weinshilboum RM; Wang L
Pharmacogenet Genomics; 2013 Mar; 23(3):156-66. PubMed ID: 23324805
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings: analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study (PGRN-AMPS) data.
Bobo WV; Angleró GC; Jenkins G; Hall-Flavin DK; Weinshilboum R; Biernacka JM
Hum Psychopharmacol; 2016 May; 31(3):185-92. PubMed ID: 26999588
[TBL] [Abstract][Full Text] [Related]
18. Influence and interaction of genetic, cognitive, neuroendocrine and personalistic markers to antidepressant response in Chinese patients with major depression.
Bi Y; Ren D; Guo Z; Ma G; Xu F; Chen Z; An L; Zhang N; Ji L; Yuan F; Liu L; Hou B; Yang F; Yu S; Yi Z; Xu Y; He L; Sun X; Dong Z; Wu S; Zhao L; Cai C; Li X; Yu T; Shi Y; He G
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110036. PubMed ID: 32702381
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
[TBL] [Abstract][Full Text] [Related]
20. Alterations in acylcarnitines, amines, and lipids inform about the mechanism of action of citalopram/escitalopram in major depression.
MahmoudianDehkordi S; Ahmed AT; Bhattacharyya S; Han X; Baillie RA; Arnold M; Skime MK; John-Williams LS; Moseley MA; Thompson JW; Louie G; Riva-Posse P; Craighead WE; McDonald W; Krishnan R; Rush AJ; Frye MA; Dunlop BW; Weinshilboum RM; Kaddurah-Daouk R;
Transl Psychiatry; 2021 Mar; 11(1):153. PubMed ID: 33654056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
